T2 Biosystems Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Sep 24 | SellUS$133 | David Elsbree | Individual | 55 | US$2.42 |
Insider Trading Volume
Insider Buying: TTOO insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 1,211 | 0.00589% |
| Individual Insiders | 1,021,160 | 4.97% |
| Hedge Funds | 1,396,000 | 6.79% |
| Institutions | 1,510,712 | 7.35% |
| General Public | 5,955,908 | 29% |
| VC/PE Firms | 10,677,973 | 51.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 407.7%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 10,677,973 | US$5.4m | 0% | 100.0% | |||
| 1,396,000 | US$712.0k | -15.8% | 0.02% | |||
| 1,000,000 | US$510.0k | 0% | no data | |||
| 755,000 | US$385.1k | 0% | 50.57% | |||
| 390,368 | US$199.1k | 24.8% | no data | |||
| 90,880 | US$46.3k | -30.3% | no data | |||
| 76,827 | US$39.2k | -1.88% | no data | |||
| 63,743 | US$32.5k | 0% | no data | |||
| 45,481 | US$23.2k | 9.16% | no data | |||
| 39,140 | US$20.0k | 0% | no data | |||
| 27,142 | US$13.8k | -30.2% | no data | |||
| 20,000 | US$10.2k | 0% | no data | |||
| 14,750 | US$7.5k | 0.31% | no data | |||
| 4,001 | US$2.0k | 40.1% | no data | |||
| 2,399 | US$1.2k | -68.7% | no data | |||
| 1,211 | US$617.7 | 0% | no data | |||
| 400 | US$204.5 | 0% | no data | |||
| 310 | US$158.4 | 0% | no data | |||
| 289 | US$147.9 | -71.4% | no data | |||
| 200 | US$101.7 | 0% | no data | |||
| 141 | US$72.4 | 0% | no data | |||
| 135 | US$69.2 | 0% | no data | |||
| 101 | US$51.4 | 0% | no data | |||
| 85 | US$43.0 | 0% | no data | |||
| 77 | US$38.8 | 0% | no data |